Cargando…

Combined modality chemoradiation in elderly oesophageal cancer patients

We present a single institution experience with 5-FU, mitomycin-C based chemoradiation for the primary treatment of elderly patients with oesophageal cancer. Twenty-five patients with a median age of 77 years (range 66–88) with a diagnosis of stage II–III squamous cell or adenocarcinoma of the oesop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, S E, Minsky, B D, Bains, M, Hummer, A, Kelsen, D, Ilson, D H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2007
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359964/ https://www.ncbi.nlm.nih.gov/pubmed/17533399 http://dx.doi.org/10.1038/sj.bjc.6603821

Ejemplares similares

Chemoradiation for oesophageal cancer: the choice of treatment modality
por: Kitti, Pauliina M., et al.
Publicado: (2023)

Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study
por: van Meerten, E, et al.
Publicado: (2006)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma
por: Crosby, T D L, et al.
Publicado: (2004)

(18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response
por: Gillham, C M, et al.
Publicado: (2006)

Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer
por: Tougeron, D, et al.
Publicado: (2008)

Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial
por: Verstraete, M, et al.
Publicado: (2015)

The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma
por: Okumura, H, et al.
Publicado: (2005)

Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma
por: Chhabra, Arpit, et al.
Publicado: (2015)

Staging investigations for oesophageal cancer: a meta-analysis
por: van Vliet, E P M, et al.
Publicado: (2008)

A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers
por: Wu, C, et al.
Publicado: (2015)

Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer
por: Millar, J, et al.
Publicado: (2005)

Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma
por: Fields, R C, et al.
Publicado: (2011)

The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer
por: McKernan, M, et al.
Publicado: (2008)

Small cell oesophageal carcinoma: an institutional experience and review of the literature
por: Hudson, E, et al.
Publicado: (2007)

Nomogram to predict ypN status after chemoradiation in patients with locally advanced rectal cancer
por: Jwa, E, et al.
Publicado: (2014)

Chemoradiation versus oesophagectomy for locally advanced oesophageal cancer in Chinese patients: study protocol for a randomised controlled trial
por: Jia, Ruinuo, et al.
Publicado: (2019)

Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer
por: Crumley, A B C, et al.
Publicado: (2006)

The role of socio-economic status in the decision making on diagnosis and treatment of oesophageal cancer in The Netherlands
por: van Vliet, E P M, et al.
Publicado: (2006)

Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer
por: Conroy, T, et al.
Publicado: (2010)

Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation
por: Gillham, Charles M, et al.
Publicado: (2007)

Molecular determinants of prognosis in oesophageal cancer patients treated with chemoradiation
por: Ajani, J A
Publicado: (2008)

Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer
por: Thomas, F, et al.
Publicado: (2011)

Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer
por: Blazeby, J M, et al.
Publicado: (2014)

Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer
por: Restivo, Angelo, et al.
Publicado: (2015)

Detection of distant metastases in patients with oesophageal or gastric cardia cancer: a diagnostic decision analysis
por: van Vliet, E P M, et al.
Publicado: (2007)

Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer
por: Rees, J, et al.
Publicado: (2015)

Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer
por: Conroy, T, et al.
Publicado: (2008)

Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)
por: Northover, J, et al.
Publicado: (2010)

The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer
por: Deans, D A C, et al.
Publicado: (2009)

Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy
por: Sultana, A, et al.
Publicado: (2007)

Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer
por: Day, F L, et al.
Publicado: (2011)

Do delays between diagnosis and surgery in resectable oesophageal cancer affect survival? a study based on West Midlands cancer registration data
por: Kötz, B S, et al.
Publicado: (2006)

Reply: molecular determinants of prognosis in oesophageal cancer patients treated with chemoradiation
por: Yoshikawa, R, et al.
Publicado: (2008)

Erlotinib and Concurrent Chemoradiation in Pretreated NSCLC Patients: Radiobiological Basis and Clinical Results
por: Ramella, Sara, et al.
Publicado: (2013)

Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery
por: Byrne, M, et al.
Publicado: (2010)

Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial
por: Verschuur, E M L, et al.
Publicado: (2009)

Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer
por: Takigawa, N, et al.
Publicado: (2006)

Hamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma
por: Reeh, Matthias, et al.
Publicado: (2017)

Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?
por: Glynne-Jones, R, et al.
Publicado: (2006)

Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy
por: Polee, M B, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_9r0hqd35mpeohb8ete86bnpnmk